| 663828 |
BIOMEDICINES |
Soluble JAM-C Ectodomain Serves as the Niche for Adipose-Derived Stromal/Stem Cells |
2021-03-10 |
10.3390/biomedicines9030278 |
Yamazaki Morio, Sugimoto Kotaro, Mabuchi Yo, Yamashita Rina, Ichikawa-Tomikawa Naoki, Kaneko Tetsuharu, Akazawa Chihiro, Hasegawa Hiroshi, Imura Tetsuya, Chiba Hideki |
| 663827 |
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY |
Prognosis of Different Types of Non-Small Cell Lung Cancer Progression: Current State and Perspectives |
2021-03-10 |
10.33594/000000340 |
|
| 663826 |
THE ONCOLOGIST |
Avelumab, a PD‐L1 Inhibitor, in Combination with Hypofractionated Radiotherapy and the Abscopal Effect in Relapsed Refractory Multiple Myeloma |
2021-03-10 |
10.1002/onco.13712 |
Kazandjian Dickran, Dew Alexander, Hill Elizabeth, Ramirez Elizabeth Gil, Morrison Candis, Mena Esther, Lindenberg Liza, Yuan Constance, Maric Irina, Wang Hao‐Wei, Calvo Katherine, Dulau‐Florea Alina, Roswarski Joseph, Emanuel Michael, Braylan Raul, Turkbey Boris, Choyke Peter, Camphausen Kevin, Stetler‐Stevenson Maryalice, Steinberg Seth M., Figg William D., Jones Jennifer |
| 663825 |
THE ONCOLOGIST |
Cervical cancer in Sub‐Saharan Africa: a multinational population‐based cohort study on patterns and guideline adherence of care |
2021-03-10 |
10.1002/onco.13718 |
Griesel Mirko, Seraphin Tobias P, Mezger Nikolaus CS, Hämmerl Lucia, Feuchtner Jana, Joko‐Fru Walburga Yvonne, Sengayi‐Muchengeti Mazvita, Liu Biying, Vuma Samukeliso, Korir Anne, Chesumbai Gladys C, Nambooze Sarah, Lorenzoni Cesaltina F, Akele‐Akpo Marie‐Thérèse, Ayemou Amalado, Traoré Cheick B, Wondemagegnehu Tigeneh, Wienke Andreas, Thomssen Christoph, Parkin Donald M, Jemal Ahmedin, Kantelhardt Eva J |
| 663824 |
THE ONCOLOGIST |
Overcoming Disparities in Cancer: A Need for Meaningful Reform for Hispanic and Latino Cancer Survivors |
2021-03-10 |
10.1002/onco.13729 |
Kronenfeld Joshua P., Graves Kristi, Penedo Frank J., Yanez Betina |
| 663823 |
THE ONCOLOGIST |
Long‐Term
Pooled Safety Analysis of Palbociclib in Combination With Endocrine Therapy for Hormone Receptor–Positive/Human Epidermal Growth Factor Receptor 2–Negative Advanced Breast Cancer: Updated Analysis With Up to 5 Years of
Fo |
2021-03-10 |
10.1002/onco.13684 |
Finn Richard S., Rugo Hope S., Gelmon Karen A., Cristofanilli Massimo, Colleoni Marco, Loi Sherene, Schnell Patrick, Lu Dongrui R., Theall Kathy Puyana, Mori Ave, Gauthier Eric, Bananis Eustratios, Turner Nicholas C., Diéras Véronique |
| 663822 |
NEURO-ONCOLOGY |
MR-guided focused ultrasound liquid biopsy enriches circulating biomarkers in patients with brain tumors |
2021-03-10 |
10.1093/neuonc/noab057 |
Meng Ying, Pople Christopher B, Suppiah Suganth, Llinas Maheleth, Huang Yuexi, Sahgal Arjun, Perry James, Keith Julia, Davidson Benjamin, Hamani Clement, Amemiya Yutaka, Seth Arun, Leong Hon, Heyn Chinthaka C, Aubert Isabelle, Hynynen Kullervo, Lipsman Nir |
| 663821 |
PEDIATRIC BLOOD & CANCER |
Results of a phase 2, multicenter, single‐arm, open‐label study of lenalidomide in pediatric patients with relapsed or refractory acute myeloid leukemia |
2021-03-10 |
10.1002/pbc.28946 |
O'Brien Maureen M., Alonzo Todd A., Cooper Todd M., Levine John E., Brown Patrick A., Slone Tamra, August Keith J., Benettaib Bouchra, Biserna Noha, Poon Jennifer, Patturajan Meera, Chen Nianhang, Simcock Mathew, Zimmerman Linda, Kolb E. Anders |
| 663820 |
PEDIATRIC BLOOD & CANCER |
Comment on: A newborn with a large NTRK fusion positive infantile fibrosarcoma successfully treated with larotrectinib |
2021-03-10 |
10.1002/pbc.28953 |
Slomovic Alana, Amaral Terry, Lobko Igor, Siegel David N, Goldfisher Rachelle, Kessel Rachel, Levy Carolyn Fein |
| 663819 |
PEDIATRIC BLOOD & CANCER |
Integrating irinotecan in standard chemotherapy: A novel dose‐density combination for high‐risk pediatric sarcomas |
2021-03-10 |
10.1002/pbc.28951 |
Bisogno Gianni, Ferrari Andrea, Tagarelli Arianna, Sorbara Silvia, Chiaravalli Stefano, Poli Elena, Scarzello Giovanni, De Corti Federica, Casanova Michela, Affinita Maria Carmen |
